This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the official electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal Register documents. Each document posted on the site includes a link to the corresponding official PDF file on govinfo.gov. This prototype edition of the daily Federal Register on FederalRegister.gov will remain an unofficial informational resource until the Administrative Committee of the Federal Register (ACFR) issues a regulation granting it official legal status. For complete information about, and access to, our official publications and services, go to About the Federal Register on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable regulatory information on FederalRegister.gov with the objective of establishing the XML-based Federal Register as an ACFR-sanctioned publication in the future. While every effort has been made to ensure that the material on FederalRegister.gov is accurately displayed, consistent with the official SGML-based PDF version on govinfo.gov, those relying on it for legal research should verify their results against an official edition of the Federal Register. Until the ACFR grants it official status, the XML rendition of the daily Federal Register on FederalRegister.gov does not provide legal notice to the public or judicial notice to the courts.
Due to the recent tragic events in the United States and resultant travel limitations, notice is hereby given of changes to the meeting of the National Advisory Allergy and Infectious Diseases Council, September 24, 8:30 AM to adjournment, Natcher Building, Conference Room D, Bethesda, MD 20892 which was published in the Federal Register on August 29, 2001, 66 FR, 45686.
The Immunology and Transplantation Subcommittee, the Microbiology and Infectious Diseases Subcommittee, and the Acquired Immunodefiency Syndrome Subcommittee will hold their closed sessions as telephone conference calls from 11:00 am to 12:30 pm.
The meeting of the National Advisory Allergy and Infectious Diseases Council will be held as a telephone conference call to review grant applications. The meeting will be held at NIH, 9000 Rockville Pike, Building 31, Room 7A03, Bethesda, MD 20802 beginning from 2:00 pm to adjournment. The meeting will be closed to the public.Start Signature
Dated: September 19, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-24361 Filed 9-27-01; 8:45 am]
BILLING CODE 440-01-M